Business Wire National BioTech News
- Miravo Healthcare™ Announces Second Quarter 2022 Results
- Antibe Therapeutics Reports Q1 2023 Interim Financial and Operating Results
- Appili Therapeutics Reports Financial and Operational Results for First Quarter of Fiscal Year 2023
- Taro Pharmaceuticals Inc. Issues Voluntary Type I Recall of Taro-Zoledronic Acid Injection, 5 mg/100 mL, 100 mL Vial Due to Particulate Matter Over Specified Requirements
- Rapid Dose Therapeutics Provides Bi-Weekly MCTO Status Update
- MedX Health Applies for Extension of Price Protection for Private Placement Convertible Loan Note Financing
- Interaxon Inc. (Muse®) Announces $9.5M Series C Funding Round To Expand Brain Health and Wellness Offerings
- GL CHEMTEC Partners with Edgewater Capital to Accelerate Growth
- IMV Inc. Announces Second Quarter 2022 Financial and Operational Results
- BELLUS Health Reports Second Quarter 2022 Financial Results and Business Highlights
RECENT TWEETS
Nova Scotia Health launches pilot program with @Virtual_Hallway to connect primary care providers with specialists to improve patient access to specialist care and reduce wait times.
@NSHealthHub @HealthNS @Doctors_NS @NSCollegeNurses https://t.co/RTZtDwz6Hq
@NSHealthHub @HealthNS @Doctors_NS @NSCollegeNurses https://t.co/RTZtDwz6Hq
Would be great to see an executive with a health and life sciences background in the leadership role with Invest Nova Scotia as NSBI & Innovacorp are both longstanding backers of the sector. https://t.co/9MqFAExXRD